Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

View:
Post by Spectracles on Dec 17, 2022 4:10am

i-Dialco

I think we have to look at more than just the deadline with Informed. Based on the press release it appears as though Dialco had specific performance targets that had to be met as well. It could be that it's better to retain 30% of a very viable company while at the same time relieving the burden of financing and sales targets while Dimi gets FDA approval. My guess is this is the best deal they could negotiate but in reality it's still a great assett for Spectral IMHO.
Comment by Revten on Dec 19, 2022 10:34pm
Looking forward to seeing more of the Specifics on this Deal. Is it possible that Spectral's 30% would be on World Wide Distribution of The Dimmi as apposed to 100% North American? If so that would just about put things right back in place for Value! And on top of that No More Royalties or Funding requirements. Just Profit!  Well let's see what comes up. Should hear something by the ...more  
Comment by mercedesman on Dec 20, 2022 8:03am
That was my thought as well Rev ! Could be that the ultimate buyer/ partner extraordinaire wants to make a much bigger play than for just NA. In any case, for Spectral, a separation of the assets is a necessary first step.   Next shoe to drop in 2023.   MM   
Comment by Accountprince on Dec 20, 2022 9:49am
MM and Rev - both of you are posters I have a lot of respect for.  Do we have any facts relating to Infomed throwing in the rest of the world into the JV deal with Spectral?  Obviously that would change the perception of the deal.  But at this stage the only facts we have are through the news release of Dec 13 - that only mentions North America.  So how does the rest of the ...more  
Comment by Spectical on Dec 20, 2022 11:33am
This post has been removed in accordance with Community Policy
Comment by mercedesman on Dec 20, 2022 12:57pm
AP. Respect you as well.  I doubt Mgt will confirm anything that is currently under discussion. Especially given their history. So we have to rely on common sense and/or speculation. If I'm Medtronics, or Braun, or Baxter, or DaVita, and I wanted to compete with one of the dominent dialysis clinic players like Fesenius (who uses the NxStage machines), I would seek out world-wide ...more  
Comment by Revten on Dec 21, 2022 8:56pm
Hello Account Prince! I do appreciate your posts and input. Thank You! What I was saying is would it be Possible that the Deal included Worldwide Distribution on the Dimmi. Seeing that Spectral got it through to FDA approval and that Home Use is the next step it would be great! Once the details of the Deal are revealed this will be clairified. I know the News said North American Distribution ...more  
Comment by Spectracles on Dec 20, 2022 12:08pm
I interpreted it to say it was just the North American market sadly. I do believe that the joint effort with Informed will be hugely profitable though so 30% may not be too bad.
Comment by Spectracles on Dec 20, 2022 12:18pm
The wording in the press release... TORONTO, Ontario–December 13, 2022 – Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (“Dialco ...more  
Comment by hmmmmmmmm on Dec 20, 2022 2:54pm
Of course it's only for N.A. there's never been a word or detail to point otherwise. Thanks for posting it in black and white. I'd add that it disengenuous for posters who know better to pump such a fake/ illogical rumor.
Comment by mercedesman on Dec 20, 2022 3:18pm
But of course it's not fake or disengenuous for other(personalities)s to post such things as: "Spectral received no value for Dialco assets - gave it all away for nothing" "Amory and Kellum in it for the lifestyle salaries & perks (i.e keys to the executive loo) "PMX soon to be worth nothing as well" "Trials won't be completed for another ...more  
Comment by hmmmmmmmm on Dec 20, 2022 5:34pm
Nope. I'm clearly on the record for calling out disengenuous bashing and pumping.   I stil don't believe the bashing or pumping on this site has any market effect, and think this board would be much more valuable as a place to share real info and as shareholder's voice to management. In my opinion saying we somehow might have partnered on world wide rights of DIMI is not ...more  
Comment by mercedesman on Dec 20, 2022 6:42pm
  I'll hold you to continuing to call out BSW and St Rather than pumping, I think a more fair characterization of my posts is that 80% + are factual in nature.  Another maybe 9% are "glass half full" posts. More often than not, in response to the outlandish bashing posts... or to fill the void of information,  using common sense to fill in the blanks.  ...more  
Comment by Revten on Dec 20, 2022 7:21pm
Spectral Medical pretty much operates as a Private Company.  information is Slowwwwwww to come but the intuitive investor reads between the lines....For "Continued Results Above Expectation "  The End Game will be A Major Success (IMHO), however we as the Minority Shareholders are at the Mercy Of Spectral Management's Timetable and therefore must be patient to The End.. ...more  
Comment by hmmmmmmmm on Dec 20, 2022 8:04pm
Ha. I can't help much with BSW as I posted that I put him on "ignore" back in Oct. adding:  "Can't you see that the whole premise for you bash and your credibility just crumble with your obvious lies?" On EMH.. the Share Price doesn't reflect known information- it reflects Spectral's management. It reflects their inability to ever start the ...more  
Comment by mercedesman on Dec 20, 2022 10:52pm
"So when you look at that track record I'd say .33 is probably fair. Our science is solid and should be worth many dollars- but the way Seto and Co. are running the show makes it high risk. As their loss of control of Dialco has just shown us" - Hmmmmm Again I say... "buy design"? How convenient for some that it IS  trading at .33. ;)  phase 1 separation ...more  
Comment by hmmmmmmmm on Dec 20, 2022 11:27pm
Sure is quite the conspiarcy so that a whopping 9 thousand dollars can trade at.33. :o Ockham's razor would be helpful when you go through all these layers of maybes..
Comment by mercedesman on Dec 21, 2022 7:39am
Like for the decease of Sepsis itself, I think that Hiccum's Dictum is more apropro in this case.  MM 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities